CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 94 filers reported holding CELL THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 5.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $130,000 | – | 38,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rotella Capital Management, Inc. | 27,000 | $28,000 | 0.09% |
| Del Mar Asset Management, LP | 95,967 | $100,000 | 0.06% |
| First Heartland Consultants, Inc. | 74,624 | $78,000 | 0.04% |
| Geduld E E | 50,000 | $53,000 | 0.04% |
| Alpine Partners USVI, LLC | 90,017 | $94,000 | 0.03% |
| CTC Alternative Strategies, Ltd. | 107,300 | $112,665,000 | 0.03% |
| WASHINGTON TRUST Co | 259,659 | $273,000 | 0.02% |
| KNIGHT CAPITAL GROUP LLC | 1,019,384 | $1,081,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 943,671 | $991,000 | 0.02% |
| Jane Street Holding, LLC | 618,516 | $649,000 | 0.01% |